Stomach Mapping in People with Stomach Motility Issues
Part of Digestive system clinical trials.
This study tests a stomach mapping device (BSGM) to see how a prokinetic medication changes stomach activity in people with gastroparesis or functional dyspepsia. If you qualify, you'll have two non-invasive recordings—one before and one during your treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a diagnosis of gastroparesis or functional dyspepsia.
- You are already taking a prokinetic medication or a symptom modulator for your stomach problem.
- You can have two stomach-mapping recordings: one before starting the medication change and one while on treatment.
- You have not had any prior stomach or esophagus surgery (except appendix or gallbladder removal).
- You are not pregnant and do not have a history of skin allergies to cosmetics or lotions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks whether a noninvasive “mapping” test placed on the belly and chest can help tell apart people with certain upper stomach symptoms from healthy controls. It may help researchers better understand stomach function and symptoms without relying only on invasive tests.
This trial compares a new stomach test (Body Surface Gastric Mapping) with a standard one (Gastric Emptying Scintigraphy) to see which helps doctors better manage gastroparesis. You may join if you have ongoing stomach symptoms like nausea or vomiting and have been referred for a stomach emptying test.
This study uses a non-invasive stomach-mapping test (BSGM) to see if a G-POEM procedure (a treatment for gastroparesis) works well. It may help doctors better understand how the stomach empties after the procedure.
This study looks at whether abnormal function of the pyloric “stomach outlet” muscle is linked to gastroparesis symptoms (slow stomach emptying). It may help researchers better understand what causes symptoms and guide future treatments.
This study uses a non-invasive test (body surface gastric mapping) to look at stomach activity in people taking semaglutide. It aims to understand how the medicine affects digestion.
This study looks at how diabetes affects stomach function by measuring stomach activity with special tests. It may help doctors better understand and treat stomach problems in people with diabetes.
Hear when a new Gastroparesis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.